Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT00420212 · COMPLETED
Trial details
- NCT number
- NCT00420212
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2011-02-01
- Enrollment
- 1234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.